Literature DB >> 2875016

Effects of vasoactive autacoids on different segments of human umbilicoplacental vessels.

K Bjøro, S Stray-Pedersen.   

Abstract

Effects of serotonin, prostaglandin E2, prostaglandin F2 alpha, U 46619 (a thromboxane A2 mimetic) and angiotensin I and II on the perfusion pressure were studied on vessel segments from human umbilical arteries, placental arteries and the umbilical vein during in vitro perfusions. All drugs were found to induce vasoconstriction. Serotonin displayed strong vasoconstrictor potencies in all vessel segments, whereas the responsiveness to the other autacoids differed greatly in the various segments. In the umbilical artery prostanoids were most potent in the juxtafetal segment, whereas angiotensin I and II displayed greatest effects in the juxtaplacental segment. The results lend additional support to the concept that angiotensins and prostanoids are of importance in the regulation of fetal extracorporeal blood flow.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875016     DOI: 10.1159/000298881

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  Pharmacological analysis of vasoconstrictor responses of isolated and perfused human umbilical arteries.

Authors:  F Yoshikawa; S Chiba
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

2.  The effect of starch glove powder on joint and other tissues.

Authors:  T Rae; L A McCormick-Thomson; D W Murray; N Rushton
Journal:  Ann R Coll Surg Engl       Date:  1989-11       Impact factor: 1.891

3.  Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein.

Authors:  J Chen; M L Champa-Rodriguez; D F Woodward
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 4.  The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation.

Authors:  Tina Napso; Hannah E J Yong; Jorge Lopez-Tello; Amanda N Sferruzzi-Perri
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.